Rephonic
Artwork for BioCentury This Week

BioCentury This Week

BioCentury
Inflation Reduction Act
Mergers and Acquisitions
Alzheimer's Disease
Schizophrenia
FDA
Biotech
Abbvie
J.P. Morgan Healthcare Conference
Arnold Ventures
Chinese Biotech
U.S. Biotech Ecosystem
CAR T Cell Therapies
CAR T
Janet Woodcock
Singapore
Antibody Drug Conjugates
Psychedelics
China
Sickle Cell Disease
JP Morgan Healthcare Conference

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs.For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

PublishesTwice weeklyEpisodes349Founded6 years ago
Number of ListenersCategories
Life SciencesScienceBusiness

Listen to this Podcast

Artwork for BioCentury This Week

Latest Episodes

Fueled by cancer, obesity and cardiovascular deals, $1 billion-plus takeouts in biotech are at their highest level in a decade with three weeks to go in the year. On the latest BioCentury This Week, BioCentury’s analysts discuss the rise in large M&A... more

YouTube

Novo Nordisk’s highly anticipated data for semaglutide in Alzheimer’s dashed hopes that the GLP-1 therapy could become a game changer in the disease. On the latest BioCentury This Week podcast, Executive Editor Selina Koch discusses the Phase III rea... more

YouTube

A baffling decision by FDA to issue a complete response letter for a pediatric medicine the medical community stood behind is just the latest example raising concerns that the agency is shifting the regulatory goalposts amid a lack of transparency. O... more

YouTube

There is cautious optimism around continued M&A momentum and the public equities markets as biotech heads into the New Year. On a special edition of the BioCentury This Week podcast recorded in London during London Life Sciences Week, BioCentury’s Si... more

YouTube

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Recent Guests

Franck Le Deu
Founder and managing partner at Curzang Ventures and senior partner at Amaretis with McKinsey
Curzang Ventures
Episode: Ep. 337 - FDA’s Moving Goalposts & China’s Innovation Arc
Al Sandrock
CEO of Voyager Therapeutics.
Voyager Therapeutics
Episode: Ep. 335 - Neurology's Coming Inflection Point
Debra Peattie
Managing Partner of SV Investments US
SV Investments
Episode: Ep. 333 - Is This Korea’s Biotech Moment?
Aram Hong
CEO of Korea MedTech Startup Apollon
Apollon
Episode: Ep. 333 - Is This Korea’s Biotech Moment?
Andy Whittle
Global Head of BDNL in the Cardio-Renal Metabolic Space for Boehringer Ingelheim
Boehringer Ingelheim
Episode: Ep. 333 - Is This Korea’s Biotech Moment?
Spencer Nam
Managing Partner of KSV Global
KSV Global
Episode: Ep. 333 - Is This Korea’s Biotech Moment?
Jim Wilson
Formerly of Penn, founder of Rare Therapeutics focused on AAV gene therapies for ultra-rare diseases.
Rare Therapeutics
Episode: Ep. 332 - Obesity in Focus. Plus: What’s Next for FDA
Matt Hewitt
VP and CTO of Charles River's Manufacturing Business Division
Charles River
Episode: Ep. 330 - China's Innovation Moment
Bing Wang
CFO of Akeso
Akeso
Episode: Ep. 330 - China's Innovation Moment

Hosts

Jeff Cranmer
Executive editor and host, bringing expertise in the biotech space.
Stephen Hansen
Director of BioPharm Intelligence, focusing on insights in biopharma.

Reviews

4.7 out of 5 stars from 72 ratings
  • terrific summaries capturing the news in this fast-moving space

    LOVE this weekly look at what is happening in biotech, both deep dives into the science itself plus the regulatory/legislative challenges and more. All the regulars are deeply knowledgeable and Jeff Cranmer’s levity as host makes the pod enjoyable and digestible--you really do feel like you have a seat at their editorial meetings. GREAT recaps of the news and in ~30 min or less, I look forward to listening each week!

    Apple Podcasts
    5
    Ios9 problem
    United Statesa year ago
  • Great insights and wisdom!

    Awesome helps me and my team navigate efficiently

    Apple Podcasts
    5
    Surfrider182
    United Statesa year ago
  • Simone Fishburn!!!!

    Simone Fishburn is so well spoken and such a tremendous host. Need more of her in our lives !!

    Apple Podcasts
    5
    Pretty Kitty 2
    United States6 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners praise the insightful analysis of current biotech trends and regulatory landscapes.
The interviews with industry experts are often highlighted for their depth and relevance.
Many comments reflect appreciation for the engaging style and clarity of complex topics.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Ep. 337 - FDA’s Moving Goalposts & China’s Innovation Arc
Q: What are the actual implications if or when the Biosecure Act does get passed?
The implications are unclear, particularly how it might impact companies involved, and would require substantial trials to establish safety outcomes associated with NLRP3 inhibitors in the context of obesity and cardiovascular risk.
Ep. 337 - FDA’s Moving Goalposts & China’s Innovation Arc
Q: Could you provide some perspective on kind of what you think the implications are for the industry related to vaccines and autism?
The CDC's statement regarding vaccines raises concerns about public health, as it implies considerable doubts about vaccine safety that could lead to the removal of essential vaccines containing aluminum, which would have horrific public health consequences.
Ep. 335 - Neurology's Coming Inflection Point
Q: What are your thoughts on neuroinflammation and its role in neurological disease?
While there is evidence of neuroinflammation, it's complex to determine whether it's a cause or effect of the disease.
Ep. 335 - Neurology's Coming Inflection Point
Q: What are you most excited about within the neurodegenerative disease drug development space?
There are disease-modifying therapies for Alzheimer's, and understanding the factors that predict treatment response is crucial.
Ep. 327 - Where Gene & Cell Therapy Go Next With Evotec's Bernd Mühlenweg
Q: What needs to happen to reduce the complexity and regulatory scrutiny of genetically engineered therapies?
An educational process is necessary between clinical sponsors and regulators to clarify the implications of genetic engineering in cell therapies.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BioCentury This Week

What is BioCentury This Week about and what kind of topics does it cover?

Focused on the evolving biotech landscape, this podcast offers insights into industry trends, regulatory challenges, and investment opportunities. It features discussions on significant developments involving leading biopharma companies, emerging technologies, and shifts in market dynamics. The content is enriched by expert interviews that provide a deeper understanding of complex scientific and regulatory landscapes, making it a vital resource for investors, executives, and professionals in the biotech field. Notably, the engaging format combines both analytical content and accessible explanations, catering to a broad audience interested in biotechnology and life sciences.

Where can I find podcast stats for BioCentury This Week?

Rephonic provides a wide range of podcast stats for BioCentury This Week. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BioCentury This Week and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BioCentury This Week get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BioCentury This Week, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BioCentury This Week?

Rephonic provides comprehensive predictive audience data for BioCentury This Week, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BioCentury This Week have?

To see how many followers or subscribers BioCentury This Week has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BioCentury This Week?

These podcasts share a similar audience with BioCentury This Week:

1. Biotech Hangout
2. The Readout Loud
3. The BioCentury Show
4. Business Of Biotech
5. Biotech 2050 Podcast

How many episodes of BioCentury This Week are there?

BioCentury This Week launched 6 years ago and published 349 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BioCentury This Week?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BioCentury This Week?

Rephonic pulls ratings and reviews for BioCentury This Week from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BioCentury This Week?

Rephonic provides full transcripts for episodes of BioCentury This Week. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BioCentury This Week?

Recent guests on BioCentury This Week include:

1. Franck Le Deu
2. Al Sandrock
3. Debra Peattie
4. Aram Hong
5. Andy Whittle
6. Spencer Nam
7. Jim Wilson
8. Matt Hewitt

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days